Author

T. Kitagawa

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Biochemistry· 1 Cancer Biology· 1 Pharmacology & Toxicology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Research Focus:host-pathogen & immune response· 2 Assay:proteomics· 2 Research Focus:cell signaling & trafficking· 1 Research Focus:cell type annotation· 1 Organism:human· 1 Organism:non-human primate· 1

Frequent Co-Authors

A. Mastumoto· 1 shared B. Baron· 1 shared D. Hamanaka· 1 shared D. Kobayashi· 1 shared D. Paudel· 1 shared H. H. Ibrahim· 1 shared H. Okita· 1 shared I. Terashima· 1 shared

Activity by Year

2020-2022 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 13 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperPharmacology & Toxicology

A. Mastumoto

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

AT-hook DNA-binding motif-containing protein one knockdown downregulates EWS-FLI1 transcriptional activity in Ewings sarcoma cells

T. Kitagawa, D. Kobayashi, B. Baron, H. Okita, T. Miyamoto, R. Takai, D. Paudel, T. Ohta, Y. Asaoka, M. Tokunaga, M. Furutani-Seiki, N. Araki, Y. Kuramitsu, M. Kobayashi

The paper identifies AHDC1 as a protein interacting with EWS-FLI1 in Ewing's sarcoma and shows its knockdown reduces cell growth and transcriptional activity.

bioRxiv · May 16, 2022 · PreprintCancer Biology

Highly efficient protein expression of Plasmodium vivax surface antigen, Pvs25 by silkworm, Bombyx mori, and its biochemical analysis.

T. Miyata, K. Minamihata, K. Kurihara, Y. Kamizuru, M. Gotanda, M. Obayashi, T. Kitagawa, K. Sato, M. Kimura, K. Oyama, Y. Ikeda, Y. Tamaki, J. M. Lee, K. Sakao, D. Hamanaka, , H. H. Ibrahim

This study expresses and purifies recombinant Pvs25 from silkworms, demonstrating its potential as a malaria transmission-blocking vaccine candidate with high immunogenicity.

bioRxiv · Mar 3, 2022 · PreprintBiochemistry

Antimalarial drugs lose their activity with a slight drop in pH

T. Kitagawa, A. Mastumoto, I. Terashima, Y. Uesono

The paper shows that antimalarial drugs lose activity with a slight pH drop due to reduced cationic amphiphilic drug (CAD) structure, affecting their efficacy against malaria and COVID-19 in acidotic conditions.

bioRxiv · Aug 4, 2020Pharmacology & Toxicology